Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
暂无分享,去创建一个
C. Finch | E. Bigio | Lei Chang | W. Klein | M. Lambert | K. Viola | G. Krafft | Yuesong Gong | P. Lacor | P. Velasco | Sara J. Fernandez | Maria C. F. Buniel
[1] J. Morrison,et al. Activity-regulated cytoskeletal-associated protein is localized to recently activated excitatory synapses , 2004, Neuroscience.
[2] Dominic M. Walsh,et al. Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease , 2004, Neuron.
[3] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[4] L. Mucke,et al. Fyn Kinase Modulates Synaptotoxicity, But Not Aberrant Sprouting, in Human Amyloid Precursor Protein Transgenic Mice , 2004, The Journal of Neuroscience.
[5] Hidekazu Tanaka,et al. Arc interacts with microtubules/microtubule‐associated protein 2 and attenuates microtubule‐associated protein 2 immunoreactivity in the dendrites , 2004, Journal of neuroscience research.
[6] R. Anwyl,et al. Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5 , 2004, The Journal of Neuroscience.
[7] D. Butterfield. Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences. , 2003, Current medicinal chemistry.
[8] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[9] C. Finch,et al. Self-assembly of Aβ1-42 into globular neurotoxins , 2003 .
[10] C. Finch,et al. Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[12] S. Deadwyler,et al. Experience-Dependent Regulation of the Immediate-Early Gene Arc Differs across Brain Regions , 2003, The Journal of Neuroscience.
[13] J. Loring,et al. Selectively Reduced Expression of Synaptic Plasticity-Related Genes in Amyloid Precursor Protein + Presenilin-1 Transgenic Mice , 2003, The Journal of Neuroscience.
[14] K. Henke,et al. Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease , 2003, Neuron.
[15] D. Butterfield,et al. Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model , 2003, Neurobiology of Aging.
[16] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[17] U. Igbavboa,et al. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. , 2003, Biochimica et biophysica acta.
[18] R. D'Hooge,et al. Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition , 2003, The European journal of neuroscience.
[19] Howard L. Weiner,et al. Inflammation and therapeutic vaccination in CNS diseases , 2002, Nature.
[20] L. Mucke,et al. Modulation of Alzheimer-Like Synaptic and Cholinergic Deficits in Transgenic Mice by Human Apolipoprotein E Depends on Isoform , Aging, and Overexpression of Amyloid β Peptides But Not on Plaque Formation , 2002, The Journal of Neuroscience.
[21] W. Klein. Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets , 2002, Neurochemistry International.
[22] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[23] D. Schenk. Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning , 2002, Nature Reviews Neuroscience.
[24] M. Kirkitadze,et al. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies , 2002, Journal of neuroscience research.
[25] B. Hyman,et al. Reversible Memory Loss in a Mouse Transgenic Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[26] K. Vrana,et al. Changes in rat frontal cortex gene expression following chronic cocaine. , 2002, Brain research. Molecular brain research.
[27] Kristen M Harris,et al. Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders? , 2002, Brain Research Reviews.
[28] Xin Wu,et al. Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model , 2002, Nature Neuroscience.
[29] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[30] A. Craig,et al. Rapid Synaptic Remodeling by Protein Kinase C: Reciprocal Translocation of NMDA Receptors and Calcium/Calmodulin-Dependent Kinase II , 2002, The Journal of Neuroscience.
[31] Brett Chromy,et al. Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus , 2002, Brain Research.
[32] H. Budka,et al. Immunohistochemistry for the Prion Protein: Comparison of Different Monoclonal Antibodies in Human Prion Disease Subtypes , 2002, Brain pathology.
[33] T. Morgan,et al. Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies , 2001, Journal of neurochemistry.
[34] O. Steward,et al. A cellular mechanism for targeting newly synthesized mRNAs to synaptic sites on dendrites , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. Balázs,et al. β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised* , 2001, The Journal of Biological Chemistry.
[36] C. Finch,et al. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.
[37] J. Sweatt,et al. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory , 2001, Journal of neurochemistry.
[38] G. Tononi,et al. Differential Expression of Plasticity-Related Genes in Waking and Sleep and Their Regulation by the Noradrenergic System , 2000, The Journal of Neuroscience.
[39] M. Inagaki,et al. Activation of Ca2+/calmodulin-dependent protein kinase II within post-synaptic dendritic spines of cultured hippocampal neurons. , 2000, The Journal of biological chemistry.
[40] A. Craig,et al. Postsynaptic Scaffolds of Excitatory and Inhibitory Synapses in Hippocampal Neurons: Maintenance of Core Components Independent of Actin Filaments and Microtubules , 2000, The Journal of Neuroscience.
[41] J. D. McGaugh,et al. Inhibition of Activity-Dependent Arc Protein Expression in the Rat Hippocampus Impairs the Maintenance of Long-Term Potentiation and the Consolidation of Long-Term Memory , 2000, The Journal of Neuroscience.
[42] Kang Hu,et al. High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.
[43] H. Moser,et al. Dendritic anomalies in disorders associated with mental retardation. , 1999, Cerebral cortex.
[44] M. Sheng,et al. Glutamate Receptor Anchoring Proteins and the Molecular Organization of Excitatory Synapses , 1999, Annals of the New York Academy of Sciences.
[45] R. Nicoll,et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[46] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[47] M. Sheng,et al. Heterogeneity in the Molecular Composition of Excitatory Postsynaptic Sites during Development of Hippocampal Neurons in Culture , 1998, The Journal of Neuroscience.
[48] J. Hainfellner,et al. Pathology and Immunocytochemistry of a Kuru Brain , 1997, Brain pathology.
[49] J. McLaurin,et al. Membrane Disruption by Alzheimer β-Amyloid Peptides Mediated through Specific Binding to Either Phospholipids or Gangliosides , 1996, The Journal of Biological Chemistry.
[50] M. Ball,et al. Water-soluble A(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (*) , 1996, The Journal of Biological Chemistry.
[51] U. Frey,et al. Somatodendritic expression of an immediate early gene is regulated by synaptic activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[52] Carol A Barnes,et al. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites , 1995, Neuron.
[53] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[54] Gareth Leng,et al. Pulsatility in Neuroendocrine Systems , 1988 .
[55] R. Katzman.,et al. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.
[56] F. Crick. Do dendritic spines twitch? , 1982, Trends in Neurosciences.
[57] E. Summary,et al. Dendrites , 1978, Journal of the Geological Society.
[58] W. Klein. Cytotoxic Intermediates in the Fibrillation Pathway: Aβ Oligomers in Alzheimer’s Disease as a Case Study , 2006 .
[59] B. Penke,et al. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. , 2004, Journal of peptide science : an official publication of the European Peptide Society.
[60] C. Finch,et al. Self-assembly of Abeta(1-42) into globular neurotoxins. , 2003, Biochemistry.
[61] K. Henke,et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. , 2003, Neuron.
[62] J. Guzowski. Insights into immediate‐early gene function in hippocampal memory consolidation using antisense oligonucleotide and fluorescent imaging approaches , 2002, Hippocampus.
[63] W Blaine Stine,et al. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. , 2002, Brain research.
[64] D. Schenk. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. , 2002, Nature reviews. Neuroscience.
[65] R. Yuste,et al. Morphological changes in dendritic spines associated with long-term synaptic plasticity. , 2001, Annual review of neuroscience.
[66] P. Greengard,et al. Intraneuronal Abeta42 accumulation in human brain. , 2000, The American journal of pathology.
[67] Anuradha Rao,et al. Signaling between the actin cytoskeleton and the postsynaptic density of dendritic spines , 2000, Hippocampus.
[68] P. Greengard,et al. Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .